NGENF
NERVGEN PHARMA CORP by NervGen Pharma Corp. (NGENF)
$20
About NERVGEN PHARMA CORP by NervGen Pharma Corp. (NGENF)
NervGen Pharma Corp. operates as a clinical stage biotech company. It provides development of treatment that enables the nervous system to repair itself following damage, whether due to injury or disease. The company was founded by Harold Punnett and William Joseph Radvak on January 19, 2017 and is headquartered in Vancouver, Canada.
Details
Daily high
$4.45
Daily low
$4.20
Price at open
$4.45
52 Week High
$5.10
52 Week Low
$1.50
Market cap
341.6M
Dividend yield
0.00%
Volume
23,702
Avg. volume
183,442
P/E ratio
-16.83
NERVGEN PHARMA CORP by NervGen Pharma Corp. News
Details
Daily high
$4.45
Daily low
$4.20
Price at open
$4.45
52 Week High
$5.10
52 Week Low
$1.50
Market cap
341.6M
Dividend yield
0.00%
Volume
23,702
Avg. volume
183,442
P/E ratio
-16.83